INTRODUCTION
Bilirubin, the main product of haem catabolism, is excreted from the hepatocytes into bile mainly as monoglucuronosylbilirubin and bisglucuronosyl bilirubin [1] [2] [3] [4] [5] . These glucuronides are formed in the endoplasmic reticulum by UDPglucuronosyl transferases of the UGT1 subfamily (reviewed in [6] ).
The secretion of compounds against a concentration gradient is mediated by ATP-dependent export pumps. Among the members of the ATP-binding cassette transporter family present in the hepatocyte canalicular membrane is the ATP-dependent conjugate export pump [7] [8] [9] [10] , also termed canalicular multispecific organic anion transporter (cMOAT) [11] . This transporter function is deficient in the hyperbilirubinaemic mutant Wistar rats GY\TR − [12] [13] [14] and Eisai hyperbilirubinaemic rats (EHBR) [15] , as well as in the human Dubin-Johnson syndrome [10, 16, 17] . Conjugated bilirubin has been considered a prominent substrate for this conjugate export pump. In the mutant rats bilirubin glucuronides accumulate in blood and liver and are eliminated largely by renal excretion [12, 13] . The impairment of ATP-dependent transport of bilirubin glucuronides has been demonstrated with hepatocyte canalicular membrane vesicles from GY\TR − mutants [18] . In addition to the transport of bilirubin glucuronides, the canalicular export of several other amphiphilic anions, including glutathione S-conjugates such as leukotriene C % (LTC % ) [19] , and glucuronidated and sulphated bile salts [14] , is deficient in these mutants. The multidrug resistance protein, MRP1, a cloned and sequenced member of Abbreviations used : BCM, bile canalicular membrane vesicles ; EHBR, Eisai hyperbilirubinaemic rat ; LTC 4 , leukotriene C 4 ; MRP1, human multidrug resistance protein 1 ; MRP2, human canalicular (apical) isoform of MRP1 ; Mrp2, canalicular isoform of rat Mrp. 1 To whom correspondence should be addressed.
membrane vesicles from mutant liver lacking Mrp2 showed no transport of the conjugates. In membrane vesicles from human hepatoma Hep G2 cells, which predominantly expressed MRP2, transport rates were 8.3 and 4.4 pmol\min per mg of protein for monoglucuronosylbilirubin and bisglucuronosylbilirubin respectively. ATP-dependent transport of the glutathione S-conjugate [$H]leukotriene C % , an established high-affinity substrate for MRP1 and MRP2, was inhibited by both bilirubin glucuronides with IC &! values between 0.10 and 0.75 µM. The ratios of leukotriene C % transport and bilirubin glucuronide transport, determined in the same membrane vesicle preparation, indicated substrate specificity differences between MRP1 and MRP2 with a preference of MRP2 for the glucuronides.
the ATP-binding cassette family of transport proteins [20] , transports a similar spectrum of substrates. It has been demonstrated that MRP1 mediates the ATP-dependent transport of glutathione S-conjugates, such as LTC % and S-(2,4-dinitrophenyl)glutathione [21] [22] [23] , in addition to the transport of glucuronidated and sulphated compounds such as 6α-glucuronosylhyodeoxycholate and 3α-sulphatolithocholyltaurine [24] . MRP1 has been detected in most cell types and tissues [20, 25, 26] .
Recently, the cDNA for the canalicular (apical) conjugate export pump deficient in GY\TR − and EHBR mutant rats has been cloned and sequenced [27, 28] . This rat transport protein was termed cMoat [27] or cMrp [28] ; the term Mrp2 is used here. The cDNA of the human homologue MRP2 (cMRP\cMOAT) has also been cloned and sequenced, and the protein has been localized to the hepatocyte canalicular membrane [10, [28] [29] [30] . MRP2 is considered a functional isoform of MRP1. MRP2 is expressed in the apical membrane of polarized cells [10, 29] .
The molecular identification of these export pumps enabled us in the present study to characterize the transport of monoglucuronosyl-and bisglucuronosyl-bilirubin mediated by these defined members of the MRP family. The ATP-dependent transport of bilirubin conjugates into inside-out oriented vesicles from MRP1-transfected HeLa cells was demonstrated and compared with Mrp2-mediated transport into rat hepatocyte canalicular membrane vesicles by using the control vector-transfected HeLa cell membranes and canalicular membrane vesicles from GY\TR − mutant liver as controls. Transport mediated by human MRP2 was characterized in membranes prepared from Hep G2 hepatoma cells, which have been shown to express large amounts of this protein under certain culture conditions. 
MATERIALS AND METHODS

Materials
Antibodies
The polyclonal anti-MRP antibody B5 was raised in our laboratory in Heidelberg against the same C-terminal amino acid sequence (residues 1517-1531) of MRP1 as the 6KQ antibody described previously [31] . The polyclonal antibody EAG 15 was raised in rabbits against the C-terminal sequence (residues 1530-1541) of rat Mrp2 [28] , and the polyclonal antibody EAG 5 was raised against the corresponding sequence of the human homologue MRP2 [10, 28] . QCRL-1, an IgG " MRP1-specific monoclonal antibody produced from mice immunized with membranes from MRP1-overexpressing H69AR cells [32] , was kindly provided by Dr. R. G. Deeley and Dr. S. P. C. Cole (Queen's University, Kingston, Ontario, Canada).
Cells
MRP1-transfected HeLa T5 and control HeLa C1 cells (transfected with the control vector) [33] , kindly provided by Dr. R. G. Deeley and Dr. S. P. C. Cole (Cancer Research Laboratories, Queen's University, Kingston, Ontario, Canada), were grown in RPMI medium (Sigma) with 10 % (v\v) fetal calf serum under the selection pressure of G418 (Geneticin2). HepG2 cells, obtained from the Tumorbank of the Deutsches Krebsforschungszentrum, Heidelberg, were grown in RPMI medium supplemented with 10 % (v\v) fetal calf serum. All cell lines were kept in a humidified incubator [air\CO # (19 : 1) ; 37 mC].
Preparation of membrane vesicles
Plasma membrane vesicles from HeLa T5, control HeLa C1 and Hep G2 cells were prepared from hypotonically lysed cells as previously described for mastocytoma cells [34, 35] . All membranes were prepared in the presence of proteinase inhibitors (0.3 µM aprotinin\1 µM leupeptin\0.1 mM PMSF\1 µM pepstatin). Membrane vesicles were frozen and stored in liquid nitrogen. Membrane fractions enriched in bile canalicular membranes were prepared from livers of normal Wistar rats and from Mrp2-deficient GY\TR − mutant rats as described [36] . Mutant rats were obtained from Dr. F. Kuipers (University of Groningen, The Netherlands).
Immunoblotting
Membrane proteins (30 µg) were separated on a 7.5 % (w\v) polyacrylamide gel. Immunoblotting with the polyclonal antibodies B5, EAG 15 and EAG 5 was performed essentially by the method of Towbin [37] with a tank blotting system and an enhanced chemoluminescence horseradish peroxidase detection system (Amersham Buchler, Braunschweig, Germany). Quantification of the MRP1 band on the autoradiographic film was performed with a laser densitometer.
Synthesis and HPLC purification of bilirubin glucuronides
Bilirubin was incubated with $H-labelled or unlabelled UDPglucuronate in the presence of microsomes (100 000 g pellet) prepared from UGT1A1 (bilirubin glucuronosyltransferase)-transfected HeLa cells. These cells had been transfected with UGT1A1 cDNA [38] . Transfection was performed with the eukaryotic expression vector pZeoSV (Invitrogen BV, Leek, The Netherlands).
Bilirubin (0.5 mM) was added from a stock solution prepared in 100 % DMSO to the incubation mixture in 50 mM Tris\HCl, pH 7.4, containing 10 mM MgCl # , 5 µM UDP-[$H]glucuronate or 1 mM UDP-glucuronate, and 20 µg of microsomal protein. 5h-AMP (4 mM) was added to inhibit the degradation of UDPglucuronate by nucleotide pyrophosphatase (EC 3.1.4.1). Incubations were terminated after 45 min at 37 mC by the addition of ethanol. Precipitated protein was removed ; the supernatant was subjected to HPLC separation on a C ") Hypersil column with a water\acetonitrile gradient running from 0 to 80 % (v\v) acetonitrile. The pH of the aqueous phase was adjusted to pH 4.8 with ammonium acetate. The identity of the separated metabolites with monoglucuronosyl-and bisglucuronosyl-bilirubin was established by electrospray ionization mass spectrometry [39] . Because the incubations with UDP-[$H]glucuronate yielded mainly mono[$H]glucuronosylbilirubin, this was incubated, after purification, for a second time with an excess of unlabelled UDP-glucuronate to yield bis[$H]glucuronosylbilirubin with the same specific radioactivity.
Transport measurements with membrane vesicles
ATP-dependent transport of [$H]LTC
% (0.05 or 0.5 µM) into membrane vesicles and its inhibition by unlabelled monoglucuronosyl-and bisglucuronosyl-bilirubin were measured by rapid filtration through nitrocellulose filters [35] . For the mono-[$H]glucuronosyl-and bis[$H]glucuronosyl-bilirubin as substrates, centrifugation of the vesicles through a gel matrix with Nick-spin columns [40] was performed. Membrane vesicles (30 µg of protein) were incubated in the presence of 4 mM ATP, 10 mM MgCl # , 10 mM creatine phosphate, 100 µg\ml creatine kinase and labelled substrate, in an incubation buffer containing 250 mM sucrose and 10 mM Tris\HCl, pH 7.4. The final incubation volume was 55 µl. The substrate and inhibitor concentrations are given in the respective Figure legends. In the rapid filtration procedure, the aliquots (15 µl) were diluted in 1 ml of ice-cold incubation buffer and immediately filtered through nitrocellulose filters (0.2 µm pore size), which had been presoaked in incubation buffer, then rinsed twice with 5 ml of incubation buffer. Filters were dissolved in liquid scintillation fluid and counted for radioactivity. In the centrifugation procedure, Nickspin columns (1 g of Sephadex G-50 per 2 ml) were prepared by being rinsed with 250 mM sucrose\10 mM Tris\HCl (pH 7.4) and then centrifuged at 400 g for 4 min at 4 mC before use. Aliquots (15 µl) of the incubations were diluted in 80 µl of icecold incubation buffer and immediately loaded on Sephadex G-50 columns. The columns were rinsed with 100 µl of incubation buffer and centrifuged at 400 g for 4 min at 4 mC. The effluents were collected and assayed for vesicle-associated radioactivity. In control experiments ATP was replaced by an equal concentration of 5h-AMP. Rates of net ATP-dependent transport were calcu-lated by subtracting values obtained in the presence of 5h-AMP as a blank from those in the presence of ATP.
RESULTS
Immunodetection of conjugate export pumps in membrane vesicle preparations
For the characterization of the different membrane preparations, immunoblot analysis was performed by means of the antibodies EAG15, B5 and EAG5, directed against the C-terminal sequences of Mrp2, MRP1 and MRP2 respectively (Figure 1 ). In addition, the monoclonal antibody QCRL-1 directed against MRP1 was used. Rat Mrp2 was detected in the canalicular membranes from normal rats with antibody EAG15 [28] , but not in the canalicular membrane preparation from transport-deficient GY\TR − mutants. Rat Mrp1 was below detectability in purified canalicular membranes [28] . Detection with antibody B5 demonstrated the overexpression of MRP1 in the membranes from HeLa T5 cells. Antibody EAG5 showed a strong reaction with MRP2 in the Hep G2 hepatoma cell membranes (Figure 1) . The latter membrane preparation was also probed with the monoclonal antibody QCRL-1 and revealed a low expression of MRP1 that was approx. 2 % of the amount of MRP1 detected in the HeLa T5 membranes as determined by analysis of the bands by laser densitometry. 4 , each at a concentration of 0.5 µM, and the rates of ATP-dependent transport were calculated as described in the legend to Figure 2 (mean values from triplicate determinations ; S.D. less than 15 % of the mean). For each membrane vesicle preparation the ratio of ATP-dependent LTC 4 transport to the ATP-dependent transport of the bilirubin glucuronides in the same membrane vesicle preparation was calculated. Abbreviation : BCM Wi , BCM from Wistar rats. determined with the normal Mrp2-expressing BCM (Table 1) . Under the conditions and at the glucuronide concentrations used, no significant transport was detected with the BCM from the Mrp2-deficient GY\TR − rats, whereas the control HeLa C1 membranes showed a transport rate of 1.7 pmol\min per mg of protein, which is in agreement with the protein detection shown in Figure 1 . ATP-dependent transport of 5 µM [$H]cholyltaurine was measured as a control to indicate that the BCM of the GY\TR − rats were functionally intact for the transport of another substrate by another ATP-dependent transport system [41] [42] [43] [40] .
Transport of mono[ 3 H]glucuronosyl bilirubin by Mrp2 and MRP1
Transport of bis[ 3 H]glucuronosylbilirubin by Mrp2 and MRP1
The membrane preparations described above were also used to study the transport of bis[$H]glucuronosylbilirubin by Mrp2 and MRP1. ATP-dependent transport was significant with bisglucuronosylbilirubin at a concentration of 0.5 µM ( Figure  3 ). As with monoglucuronidated bilirubin, the BCM from normal Mrp2-expressing rats showed a higher transport activity for the glucuronide than the MRP1-expressing HeLa T5 membranes (Table 1 ). There was no significant ATP-dependent transport of bisglucuronosylbilirubin in BCM from GY\TR − liver. The transport rates in the control HeLa C1 membranes were less than 0.5 pmol\min per mg of protein.
ATP-dependent transport of mono[ 3 H]glucuronosyl bilirubin and bis[ 3 H]glucuronosylbilirubin into membrane vesicles from human hepatoma Hep G2 cells expressing MRP2
Transport of mono[$H]glucuronosyl-and bis[$H]glucuronosyl-
bilirubin was measured at a concentration of 0.5 µM in membranes from human Hep G2 cells (Figure 4 ), which express, under the conditions described here, mainly MRP2 and a very small amount of MRP1 (Figure 1 ). Similarly to the results obtained for MRP1 (Figures 2 and 3 ), monoglucuronosylbilirubin was a better transport substrate than bisglucuronosyl bilirubin for human MRP2 in these membranes (Figure 4 ).
Relative transport rates for [ 3 H]leukotriene C 4, mono[ 3 H]glucuronosylbilirubin and bis[ 3 H]glucuronosylbilirubin in membrane vesicles containing different MRP isoforms
The relative rates of ATP-dependent transport of [$H]LTC % , mono[$H]glucuronosylbilirubin and bis[$H]glucuronosylbilirubin were determined in human Hep G2 membranes rich in MRP2, in Mrp2-containing rat BCM and in membranes from HeLa T5 cells (Table 1) . LTC % , at a concentration of 0.5 µM, was transported at a higher rate by MRP1 in HeLa T5 membranes than by Mrp2 in the BCM from normal rats or by MRP2 in Hep G2 membranes (Table 1) . Conversely, transport rates of both bilirubin glucuronides by the MRP2-containing HepG2 and the Mrp2-containing BCM membrane preparations were higher than with MRP1-rich membrane vesicles from HeLa T5 cells. The ratios of the transport rates of these different substrates in a defined membrane vesicle preparation indicate a preference of MRP2 (and Mrp2) for the bilirubin glucuronides as substrates in comparison with the glutathione conjugate LTC % ( Table 1 ). 
Inhibition of [ 3 H]leukotriene C 4 transport by monoglucuronosylbilirubin and bisglucuronosylbilirubin
DISCUSSION
The identification of MRP1 as a primary active ATP-dependent export pump for glutathione S-conjugates suggested that it might have a substrate specificity similar to that of the MRP2 geneencoded conjugate export pump in the hepatocyte canalicular membrane [21] [22] [23] . It has been suggested on the basis of studies in normal and transport-deficient mutant rats [8] [9] [10] [11] [12] [13] [14] [15] , and has been demonstrated more recently for recombinant MRP1, that, in addition to glutathione S-conjugates, certain glucuronidated and sulphated compounds can be transport substrates for both conjugate export pumps [24, 44] . MRP1-mediated ATP-dependent transport was shown for the steroid conjugates 17β-glucuronosyloestradiol, 6α-glucuronosylhyodeoxycholate, and 3α-sulphatolithocholyltaurine, as well as for the epipodophyllotoxin conjugate glucuronosyletoposide [24] . Despite the fact that amphiphilic anions of considerably different structures are transported by the same protein, a remarkable selectivity could be observed in some cases. This is exemplified by some steroid conjugates, among them 3α-sulphatooestradiol and cholyltaurine, which are not MRP1 substrates [24] . MRP1 was originally cloned and sequenced from multidrug-resistant lung cancer cells [20] and encodes an integral membrane glycoprotein of approx. 190 kDa [33] . The recently cloned rat mrp2 cDNA, as well as its human homologue MRP2, also encodes membrane glycoproteins of approx. 190 kDa with a similar predicted structure [10, [27] [28] [29] [30] . The amino acid sequences of these canalicular (apical) isoforms, however, are markedly different from that of MRP1. The amino acid sequence of Mrp2 displays 48 % identity with, and 68 % similarity to, MRP1 [28] . Therefore it was also of interest to study possible differences in substrate specificity or function. Because of the demonstration of the selective loss of Mrp2 in GY\TR − and EHBR mutant canalicular membranes [27, 28] , the canalicular membrane vesicles from normal compared with mutant rat liver provide a well-defined tool for the characterization of Mrp2-mediated transport. Bilirubin glucuronides have been considered physiologically the most important substrates for Mrp2.
In the present study we show for the first time that both monoglucuronosylbilirubin and bisglucuronosylbilirubin are transported ATP-dependently by human recombinant MRP1 (Figures 2 and 3) . The conjugation of bilirubin with $H-labelled glucuronate of high specific radioactivity yielded labelled substrates well suited for transport assays in isolated membrane vesicles. The relative transport rates of both bilirubin glucuronides and of LTC % (Table 1) , as well as inhibition studies ( Figure 5 ), indicated differences in the substrate specificities of both transporters. Although we do not know the absolute transporter protein content in the membrane preparations and therefore cannot compare absolute transport rates, the ratios of LTC % and bilirubin glucuronide transport determined in a single membrane preparation were significantly different between MRP1-expressing and Mrp2-expressing membranes. For LTC % , the transport rates obtained with normal rat liver BCM were markedly lower than with HeLa T5 membranes, whereas for monoglucuronosyl and bisglucuronosyl bilirubin the transport rates were significantly higher in the canalicular membranes (Table 1) . In HeLa T5 membranes monoglucuronosyl bilirubin was transported at a significantly higher rate than the bisglucuronide ; however, both bilirubin conjugates were transported at similar rates in BCM (Figures 2 and 3 and Table 1 ). Under the conditions used, we could not detect a significant ATP-dependent transport of bilirubin glucuronides in BCM from the Mrp2-deficient GY\TR − rat liver (Figures 2 and 3 ). This finding is in line with previous studies by Nishida et al. [18] . In i o, however, the biliary output of bilirubin and its conjugates in GY\TR − rats is decreased to only approx. 40 % of normal [12] . In bile from the mutant rat, bisglucuronosylbilirubin is the major bilirubin conjugate, whereas in normal rat bile monoglucuronosyl-and bisglucuronosyl-bilirubin are present in almost equal proportions [12] . The presence of bilirubin glucuronides in the bile of GY\TR − rats indicates that a low-affinity secretion of these conjugates is still active in the canalicular membrane of the mutants. It has been suggested that this residual biliary excretion is caused by a non-ATP-dependent transport process driven by the membrane potential and possibly mediated by the same protein [11, 18] . This proposed bifunctional activity of the transporter can now be excluded after the molecular identification of the canalicular conjugate export pump and the demonstration of the absence of Mrp2 in GY\TR − membranes [27, 28] . These observations indicate that, at least at higher bilirubin glucuronide concentrations, an additional transport system might become involved. This system would not mediate the transport of other known Mrp2 substrates, such as LTC % , whose biliary excretion in the GY\TR − rats is impaired by more than 95 % [19, 45] .
The Hep G2 cell line has been chosen for a study of bilirubin glucuronide transport mediated by human MRP2 because of the high expression of the MRP2 protein and the very low MRP1 expression in these cells under our culture conditions ( Figure 1 ). As has been observed for Mrp2 in rat canalicular membranes, the ratios of the transport rates of LTC % and bilirubin glucuronides were markedly lower than in HeLa T5 membranes (Table 1) . This indicates that MRP2 is better suited for bilirubin glucuronide transport and MRP1 is more active in LTC % transport. In contrast with rat Mrp2, human MRP2 seems to transport the more hydrophobic monoglucuronosylbilirubin significantly better than the more hydrophilic bisglucuronosyl bilirubin. The effective inhibition of MRP1-mediated and MRP2-mediated transport of the high-affinity substrate LTC % by both bilirubin glucuronides suggests a high-affinity binding of both bilirubin glucuronides to MRP1, Mrp2 and MRP2 ( Figure 5 ).
Our studies establish that monoglucuronosyl bilirubin and bisglucuronosylbilirubin are substrates for ATP-dependent transport by human MRP1, MRP2 and the rat homologue Mrp2. Moreover, measurements of relative transport rates suggest that substrate specificity differences exist between both conjugate export pumps. These kinetic differences should be characterized in further detail after the reconstitution of purified MRP1 and MRP2 into proteoliposome vesicles.
